Change is complex: Rethinking research on psychosocial interventions and cancer

Integrative Cancer Therapies

Volumn 1, Issue 2, 2003, Pages 135-145

  Temoshok, Lydia R ^a,b   Wald, Rebecca L ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST TUMOR; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; FEMALE; GROUP THERAPY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; ONCOLOGY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; REVIEW; SELF REPORT; SOCIAL ASPECT; SOCIAL SUPPORT;

BREAST NEOPLASMS; FEMALE; HUMANS; PSYCHOTHERAPY, GROUP; RESEARCH DESIGN;

EID: 0037586598     PISSN: 15347354     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534735402001002005     Document Type: Review

References (46)

1. Fox BH. The contribution of the mind to health and disease has been underresearched not underestimated. Advances: J Mind-Body Health. 1995;11:12-14.
2. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989;2:888-891.
3. Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001;345:1719-1726.
4. Spiegel S. Mind matters: Group therapy and survival in breast cancer. N Engl J Med. 2001;345:1767-1768.
5. Temoshok L, Dreher H. The Type C connection: The Behavioral Links to Cancer and Your Health. New York: Random House; 1992.
6. Spiegel D, Classen C. Group Therapy for Cancer Patients: A Research-Based Handhook of Psychosocial Care. New York: Basic Books; 2000.
7. Classen C, Butler LD, Koopman C, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychia. 2001;58:494-501.
8. Greer S, Moorey S, Baruch JDR, et al. Adjuvant psychological therapy for patients with cancer: a prospective randomized trial. Brit Med J. 1992;304:675-680.
9. Cunningham AJ, Edmonds CVI, Phillips C, Soots KI, Hedley D, Lockwood GA. A prospective, longitudinal study of the relationship of psychological work to duration of survival in patients with metastatic cancer. Psycho-oncol. 2000;9:323-339.
10. Le Shan L. Cancer As a Turning Point. New York: E.P. Dutton, 1989.
11. Temoshok L, DiClemente RJ, Sweet DM, Blois MS, Sagebiel RW. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer 1984;54:3048-3053.
12. Kneier AW, Temoshok L. Repressive coping reactions in patients with malignant melanoma as compared to cardiovascular disease patients. J Psychosomatic Research. 1984;28:145-155.
13. Temoshok L, Heller BW, Sagebiel RW, et al. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosomatic Research. 1985;29:139-153.
14. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: Psychological factors associated with prognostic indicators, progression, psychophysiology, and tumor-host response. Social Science and Medicine. 1985;20:833-840.
15. Solomon GF, Kemeny ME, Temoshok L. Psychoneuroimmunologic aspects of human immunodeficiency virus infection. In: Ader R, Felten DL, Cohen N, eds. Psychoneuroimmunology. 2nd ed. San Diego, Calif: Academic Press; 1991:1081-1114.
16. Solano L, Costa, M, Temoshok L, et al. An emotionally inexpressive (Type C) coping style influences HIV disease progression at six and twelve month follow-ups. Psychology & Health. 2002; (in press).
17. Friedman M, Thoresen CE, Gill JJ, et al. Alteration of type A behavior and its effect on cardiac recurrences in postmyocardial infarction patients: summary results of the recurrent coronary prevention project. Amer Heart J. 1986;112:653-665.
18. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R. Stress-related changes in proinflammatory cytokine production in wounds. Lancet 1995;346:1194-1196.
19. Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL. Personality as an independent predictor of long-term mortality in patients with coronary heart disease. Lancet. 1996;347:417-421.
20. Fox BH. A hypothesis about Spiegel et al.'s 1989 paper on psychosocial intervention and breast cancer survival. Psycho-Oncol. 1998;7:361-370.
21. Spiegel D, Kraemer HC, Bloom JR. A tale of two methods: randomization versus matching trials in clinical research. Psycho-Oncol. 1998;7:371-375.
22. Spiegel D, Bloom JR, Yalom I. Group support for patients with metastatic cancer: a randomized outcome study. Arch Gen Psychiat. 1981;38:527-533.
23. McNair DM, Lorr M, Droppleman LF. EDITS manual for the Profile of Mood States. Rev ed. San Diego, Calif: Educational and Industrial Testing Service; 1992.
24. Temoshok L, Fox BH. Coping styles and other psychosocial factors related to medical status and to prognosis in patients with cutaneous malignant melanoma. In: Fox BH, Newberry BH, eds. Impact of Psychoendocrine Systems in Cancer and Immunity. Lewiston, NY: C.J. Hogrefe; 1984:258-287.
25. Temoshok L. Personality, coping style, emotion, and cancer: Toward an integrative model. Cancer Surveys. 1987;6:837-857.
26. Temoshok, L. Psychological response and survival in breast cancer. Lancet. 2000;355:404-405.
27. Weinberger DA, Schwartz GE, Davidson RJ. Low-anxious, high-anxious, and repressive coping styles: psychometric patterns and behavioral and physiological responses to stress. J Abnormal Psych. 1979;88:369-380.
28. Temoshok L. Complex coping patterns and their role in adaptation and neuroimmunomodulation: theory, methodology, and research. Ann New York Acad Science. 2000;917:446-455.
29. Temoshok LR. Type C: A hypothesized psychosocial risk factor for cancer. In: Fernandez-Bellesteros R, ed. Encyclopedia of Psychological Assessment. New York: Sage; 2002 (in press).
30. Solano L, Costa M, Salvati S. Psychosocial factors and clinical evolution in HIV-infection: a longitudinal study. J Psychosomatic Res. 1993;37:39-51.
31. Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA 1979;242:1504-1508.
32. Vingerhoets A, van Bussel F, Boelhouwer J, eds. The (Non) Expression of Emotions in Health and Disease. Tilburg, The Netherlands: Tilburg University Press; 1997.
33. Nycliçek I, Vingerhoets A, Temoshok L, eds. Emotional Expression and Health. London, UK: Brunner-Routledge. In press.
34. Cunningham AJ, Edmonds CV, Jenkins GP. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psycho-oncol. 1998;7:508-517.
35. Cunningham AJ, Phillips C, Lockwood GA, Hedley D, Edmonds CVI. Association of involvement in psychological self help with longer survival in patients with metastatic cancer; an exploratory study. Advances in Mind-Body Medicine. 2000;16:276-287.
36. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129-136.
37. Temoshok LR. The complexity of cause: linking emotional dynamics to health outcomes. In: Vingerhoets A, van Bussel F, Boelhouwer J, eds. The (Non) Expression of Emotions in Health and Disease. Tilburg, The Netherlands: Tilburg University Press; 1997:15-24.
38. Spiegel D. Commentary: Psychosocial intervention in cancer. J Nat Cancer Inst. 1993;85:1198-1205.
39. Zilberg NJ, Weiss DS, Horowitz MJ. Impact of events scale: a cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes. J Consult Clin Psychol. 1982;50:407-414.
40. Block KI. Psychooncology and total survivorship. Advances in Mind-Body Medicine. 1999;15:236-281.
41. Greer S, Morris T, Pettingale KW, Haybittle JL. Psychological response to breast cancer and 15 year outcome. Lancet. 1990;1: 49-50
42. Fawzy FI, Fawzy NW, Hyun CS, et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiat. 1993;50:681-689.
43. Coyne JC, Racioppo MW. Never the twain shall meet? Closing the gap between coping research and clinical intervention research. American Psychologist. 2000;55:655-664.
44. Fox BH. Some problems and some solutions in research on psychotherapeutic intervention in cancer. Support Care Cancer. 1995;3:244-251.
45. Greer S. Mind-body research in psychooncology. Advances in Mind-Body Medicine. 1999;15:236-244.
46. Fawzy FI. Immune effects of a short-term intervention for cancer patients. Advances. 1994;10:32-33.